(Q44335990)

2 December 2017

Differential effects of systemically administered nor-binaltorphimine (nor-BNI) on kappa-opioid agonists in the mouse writhing assay (English)

1 reference

2 December 2017

0 references

J H Broadbear

1

1 reference

2 December 2017

S S Negus

2

1 reference

2 December 2017

E R Butelman

3

1 reference

2 December 2017

B R de Costa

4

1 reference

2 December 2017

J H Woods

5

1 reference

2 December 2017

1 July 1994

1 reference

2 December 2017

1 reference

2 December 2017

115

1 reference

2 December 2017

3

1 reference

2 December 2017

311-319

1 reference

https://scigraph.springernature.com/pub.10.1007/bf02245071

2 December 2017

0 references

cites work

Bremazocine is an agonist at kappa-opioid receptors and an antagonist at mu-opioid receptors in the guinea-pig myenteric plexus

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02245071

Differential sensitivity of models of antinociception in the rat, mouse and guinea-pig to mu- and kappa-opioid receptor agonists

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02245071

CI-977, a novel and selective agonist for the kappa-opioid receptor

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02245071

The binding spectrum of narcotic analgesic drugs with different agonist and antagonist properties

21 January 2018

1 reference

12 December 2020

A novel opioid receptor site directed alkylating agent with irreversible narcotic antagonistic and reversible agonistic activities

1 reference

12 December 2020

Interaction of beta-funaltrexamine with [3H]cycloFOXY binding in rat brain: further evidence that beta-FNA alkylates the opioid receptor complex

1 reference

12 December 2020

Norbinaltorphimine: antagonist profile at kappa opioid receptors

1 reference

12 December 2020

Differential antagonism of U69,593- and bremazocine-induced antinociception by (-)-UPHIT: evidence of kappa opioid receptor multiplicity in mice

1 reference

12 December 2020

[3H]U-69593 a highly selective ligand for the opioid kappa receptor

1 reference

12 December 2020

A brief study of the selectivity of norbinaltorphimine, (-)-cyclofoxy, and (+)-cyclofoxy among opioid receptor subtypes in vitro

1 reference

12 December 2020

Endorphinergic Mechanisms in Food, Salt and Water Intake: An Overview

1 reference

12 December 2020

The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog

1 reference

12 December 2020

Interactions between mu and kappa opioid agonists in the rat drug discrimination procedure

1 reference

12 December 2020

U-50,488, a selective kappa opioid agonist: Comparison to other reputed kappa agonists

1 reference

12 December 2020

Differential antagonism of opioid delta antinociception by [D-Ala2,Leu5,Cys6]enkephalin and naltrindole 5'-isothiocyanate: evidence for delta receptor subtypes

1 reference

12 December 2020

Evaluation of the receptor selectivities of opioid drugs by investigating the block of their effect on urine output by beta-funaltrexamine

1 reference

12 December 2020

Binaltorphimine and nor-binaltorphimine, potent and selective kappa-opioid receptor antagonists

1 reference

12 December 2020

Interaction of endogenous opioid peptides and other drugs with four kappa opioid binding sites in guinea pig brain

1 reference

12 December 2020

Nor-binaltorphimine, a highly selective kappa-opioid antagonist in analgesic and receptor binding assays

1 reference

12 December 2020

Kappa opioid antagonist effects of systemically administered nor-binaltorphimine in a thermal antinociception assay in rhesus monkeys.

1 reference

12 December 2020

Anatomy of CNS opioid receptors

1 reference

12 December 2020

Dog cerebral cortex contains mu-, delta- and kappa-opioid receptors at different densities: apparent lack of evidence for subtypes of the kappa-receptor using selective radioligands

1 reference

12 December 2020

Use of beta-funaltrexamine to determine mu opioid receptor involvement in the analgesic activity of various opioid ligands

1 reference

12 December 2020

In vivo studies on spinal opiate receptor systems mediating antinociception. II. Pharmacological profiles suggesting a differential association of mu, delta and kappa receptors with visceral chemical and cutaneous thermal stimuli in the rat.

1 reference

12 December 2020

Effects of kappa opiate agonists on neurochemical and neuroendocrine indices: evidence for kappa receptor subtypes.

1 reference

12 December 2020

Multiple opiate receptors: Differential binding of μ, κ and δ agonists

1 reference

12 December 2020

Characterization of kappa opioid binding using dynorphin A1-13 and U69,593 in the rat brain.

1 reference

12 December 2020

Bremazocine induces antinociception, but prevents opioid-induced constipation and catatonia in rats and precipitates withdrawal in morphine-dependent rats

1 reference

12 December 2020

Endogenous opioid peptides: multiple agonists and receptors

1 reference

12 December 2020

Extremely long-lasting antagonistic actions of nor-binaltorphimine (nor-BNI) in the mouse tail-flick test

1 reference

12 December 2020

Bremazocine: A potent, long-acting opiate kappa-agonist

1 reference

12 December 2020

Suppression by nor-binaltorphimine of kappa opioid-mediated diuresis in rats

1 reference

12 December 2020

Naltrindole, a highly selective and potent non-peptide delta opioid receptor antagonist

1 reference

12 December 2020

Characterization and visualization of rat and guinea pig brain kappa opioid receptors: evidence for kappa 1 and kappa 2 opioid receptors

1 reference

12 December 2020

Stereoisomeric 5,9-dimethyl-2'-hydroxy-2-tetrahydrofurfuryl-6,7-benzomorphans, strong analgesics with nonmorphinelike action profiles

1 reference

12 December 2020

Long term kappa-opioid receptor blockade following nor-binaltorphimine

1 reference

12 December 2020

Kappa opiate receptor multiplicity: evidence for two U50,488-sensitive kappa 1 subtypes and a novel kappa 3 subtype.

1 reference

12 December 2020

Species differences in the concentrations and distributions of opioid binding sites

1 reference

12 December 2020

Multiple mu opiate receptors: biochemical and pharmacological evidence for multiplicity

1 reference

12 December 2020

A novel, potent and selective nonpeptidic delta opioid receptor agonist BW373U86.

1 reference

12 December 2020

Pharmacological characterization in vivo of the novel opiate, beta-funaltrexamine

1 reference

12 December 2020

Kappa opioid agonists and antagonists: effects on drinking and urinary output

1 reference

12 December 2020

Differential antagonism of delta opioid agonists by naltrindole and its benzofuran analog (NTB) in mice: evidence for delta opioid receptor subtypes

1 reference

12 December 2020

Nor-binaltorphimine: a potent and selective kappa-opioid receptor antagonist with long-lasting activity in vivo

1 reference

12 December 2020

Pharmacological analysis of the discriminative stimulus characteristics of ethylketazocine in the rhesus monkey.

1 reference

12 December 2020

Endorphins and food intake: kappa opioid receptor agonists and hyperphagia

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02245071

1 reference

2 December 2017

1 reference